Addex Therapeutics

Developer of oral small molecules for neurological disorders

placeGeneva, Geneva, Switzerland calendar_todayFounded 2002 groups24 employees language addextherapeutics.com

Social engagement

Social engagement: 7.7K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

24 investors on record; lead investors include SR One, Roche, TVM; 1 has since exited.

Investor typeCountShare
Venture capital1146%
Other / undisclosed1354%

Recent activity

1 Dec 2025
Event
Financial Results Release
Coming soon